Asensus Surgical Inc (ASXC)’s financial ratios: A comprehensive overview

After finishing at $0.31 in the prior trading day, Asensus Surgical Inc (AMEX: ASXC) closed at $0.29, down -4.81%. In other words, the price has decreased by -$0.0149 from its previous closing price. On the day, 899642 shares were traded.

Ratios:

Our goal is to gain a better understanding of ASXC by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.24 and its Current Ratio is at 3.79. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.10.

On September 08, 2022, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $1.50.

On May 26, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $4.H.C. Wainwright initiated its Buy rating on May 26, 2021, with a $4 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 14 when Starling William N JR bought 18,134 shares for $0.28 per share. The transaction valued at 5,078 led to the insider holds 39,134 shares of the business.

Starling William N JR sold 18,134 shares of ASXC for $5,078 on Dec 14. The Director now owns 0 shares after completing the transaction at $0.28 per share.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ASXC now has a Market Capitalization of 78.15M and an Enterprise Value of 50.55M. For the stock, the TTM Price-to-Sale (P/S) ratio is 13.90 while its Price-to-Book (P/B) ratio in mrq is 1.65. Its current Enterprise Value per Revenue stands at 9.01 whereas that against EBITDA is -0.67.

Stock Price History:

Over the past 52 weeks, ASXC has reached a high of $0.86, while it has fallen to a 52-week low of $0.20. The 50-Day Moving Average of the stock is 0.3020, while the 200-Day Moving Average is calculated to be 0.3420.

Shares Statistics:

The stock has traded on average 1.25M shares per day over the past 3-months and 1.01M shares per day over the last 10 days, according to various share statistics. A total of 264.32M shares are outstanding, with a floating share count of 259.00M. Insiders hold about 2.01% of the company’s shares, while institutions hold 9.96% stake in the company. Shares short for ASXC as of Feb 15, 2024 were 17.05M with a Short Ratio of 13.69, compared to 19.41M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 6.43% and a Short% of Float of 6.55%.

Earnings Estimates

Its stock is currently analyzed by 1 different market analysts. On average, analysts expect EPS of -$0.08 for the current quarter, with a high estimate of -$0.08 and a low estimate of -$0.08, while EPS last year was -$0.08. The consensus estimate for the next quarter is -$0.05, with high estimates of -$0.05 and low estimates of -$0.05.

Analysts are recommending an EPS of between -$0.33 and -$0.33 for the fiscal current year, implying an average EPS of -$0.33. EPS for the following year is -$0.19, with 1 analysts recommending between -$0.19 and -$0.19.

Revenue Estimates

1 analysts predict $5.3M in revenue for the current quarter. It ranges from a high estimate of $5.3M to a low estimate of $5.3M. As of the current estimate, Asensus Surgical Inc’s year-ago sales were $2.46M, an estimated increase of 115.10% from the year-ago figure. For the next quarter, 1 analysts are estimating revenue of $1.5M, an increase of 53.70% less than the figure of $115.10% in the same quarter last year. There is a high estimate of $1.5M for the next quarter, whereas the lowest estimate is $1.5M.

A total of 1 analysts have provided revenue estimates for ASXC’s current fiscal year. The highest revenue estimate was $8.4M, while the lowest revenue estimate was $8.4M, resulting in an average revenue estimate of $8.4M. In the same quarter a year ago, actual revenue was $7.09M, up 18.50% from the average estimate. Based on 1 analysts’ estimates, the company’s revenue will be $11.8M in the next fiscal year. The high estimate is $11.8M and the low estimate is $11.8M. The average revenue growth estimate for next year is up 40.50% from the average revenue estimate for this year.

Most Popular

[the_ad id="945"]